The value of phytoestrogens as a possible therapeutic option in postmenopausal women with coronary heart disease

Journal of Obstetrics and Gynaecology

Volumn 19, Issue 5, 1999, Pages 455-459

  Finking, G ^a,b   Hess, Beate ^a   Hanke, H ^a  

^a UNIVERSITY OF ULM   (Germany)

^b UNIVERSITY HOSPITAL ULM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DAIDZEIN; ESTROGEN; ESTROGEN RECEPTOR; GENISTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PHYTOESTROGEN;

ARTERY WALL; BONE METABOLISM; BREAST CANCER; CORONARY RISK; ENDOMETRIUM CANCER; ESTROGEN THERAPY; FEMALE; HUMAN; ISCHEMIC HEART DISEASE; LIPID METABOLISM; POSTMENOPAUSE; PRIORITY JOURNAL; SHORT SURVEY;

EID: 0032846614     PISSN: 01443615     EISSN: None     Source Type: Journal    
DOI: 10.1080/01443619964184     Document Type: Short Survey

References (61)

1. Abraham G. E., Odell W. D., Swerdloff R. S. and Hopper K. (1972) Simultaneous radioimmunoassay of plasma FSH, LH, progesterone, 17-Hydroxyprogesterone, and estradiol-17β during the menstrual cycle. Journal of Clinical Endocrinology, 34, 312-318.
2. Adams M. R., Register T. C., Golden D. L., Wagner J. D. and Williams J. K. (1997) Medroxyprogesterone acetate antagonizes inhibitory effects of conjugated equine estrogens on coronary artery atherosclerosis. Arteriosclerosis Thrombosis and Vascular Biology, 17, 217-221.
3. Adlercreutz H., Markkanen H. and Watanabe S. (1993) Plasma concentrations of phyto-oestrogens in Japanese men. Lancet, 342, 1209-1210.
4. Akiyama T., Ishida J., Nakagawa S., Ogawara H., Watanabe S., Itoh N., Shibuya M. and Fukami Y. (1987) Genistein, a specific inhibitor of tyrosine-specific protein kinases. Journal of Biological Chemistry, 262, 5592-5595.
5. Anthony M. S., Clarkson T. B., Hughes C. L., Jr Morgan T. M. and Burke G. L. (1996) Soybean isoflavones improve cardiovascular risk factors without affecting the reproductive system of peripubertal rhesus monkeys. Journal of Nutrition, 126, 43-50.
6. Barnes S. (1995) Effect of Genistein on in vitro and in vivo models of cancer. Journal of Nutrition, 125, 777S-783S.
7. Barnes S. (1998) Evolution of the health benefits of soy isoflavones. Proceedings of the Society for Experimental Biology and Medicine, 217, 386-392.
8. Barrett-Connor E. (1997) The sex differences in coronary heart disease. Why are women so superior? The 1995 Ancel Keys Lecture. Circulation, 95, 252-264.
9. Bath P. M., Hassall D. G., Gladwin A. M., Palmer R. M. and Martin J. F. (1991) Nitric oxide and prostacyclin. Divergence of inhibitory effects on monocyte chemotaxis and adhesion to endothelium in vitro. Arteriosclerosis and Thrombosis, 11, 254-260 (abstract).
10. Berkson D. M., Stamler J. and Cohen D. B. (1964) Ovarian Junction and coronary atherosclerosis. Clinical Obstetrics and Gynecology. 7, 504-530.
11. Bischof G., Illek B., Reenstra W. W. and Machen T. E. (1995) Role for tyrosine kinases in carbachol-regulated Ca entry into colonic epithelial cells. American Journal of Physiology, 268, 154C-161C.
12. Bjarnson N. H., Haarbo J., Byrjalsen I., Kauffmann R. F. and Christiansen C. (1997) Raloxifene inhibits aortic accumulation of cholesterol in ovariectomized, cholesterol-fed rabbits. Circulation, 96, 1964-1969.
13. Brehme U., Bruck B., Gugel N., Hanke S., Schmahl F. W., Haasis R. and Hanke H. (1997) Tierexperimentelle Unter-suchungen zur Wirkung verschiedener Hormon-Kombinationen auf die Plaquebildung in der Aorta and die Proliferation des Endometriums. Perfusion, 2, 83-84 (abstract).
14. Bruck B., Seitz D., Hanke S., Lange K., Schmahl F. W., Haasis R. and Hanke H. (1996) Bone mineral density in premenopausal women with oestrogen deficiency and symptomatic coronary heart disease. British Journal of Clinical Practice, 50, 450-453.
15. Cataldi M., Taglialatcla M., Guerriero S., Amoroso S., Lombardi G., di-Renzo G and Annunziato L. (1996) Protein-tyrosine kinases activate while protein-tyrosine phosphatases inhibit L-type calcium channel activity in pituitary GH3 cells. Journal of Biological Chemistry, 271, 9441-9446.
16. Chen S.-J., Li H., Durand J., Oparil S. and Chen Y.-F. (1996) Estrogen reduces myointimal proliferation after balloon injury of rat carotid artery. Circulation, 93, 577-584.
17. Chiang C. E., Chen S. A., Chang M. S., Lin C. I. and Luk H. N. (1996) Genistein directly inhibits L-type calcium currents but potentiates cAMP-dependent chloride currents in cardiomyocytes. Biochemical and Biophysical Research Communications, 223, 598-603.
18. Collins P., Rosano G. M. C., Sarrel P. M., Ulrich L., Adamopoulos S., Beale C. M., McNeill J. G. and Poole-Wilson P. A. (1995) 17β-estradiol attenuates acetylcholine-induced coronary arterial constriction in women but not men with coronary heart disease. Circulation, 92, 24-30.
19. Coward L., Kirk M., Albin N. and Barnes S. (1996) Analysis of plasma isoflavones by reversed-phase HPLC-multiple reaction monitoring-mass spectrometry. Clinical Chemical Acta, 247, 121-142.
20. Delmas P. D., Bjarnson N. H., Mitlak B. H., Ravoux A. C., Shah A. S., Huster W. J., Draper M. and Christiansen C. (1997) Effects of raloxifene on bone mineral density, serum cholesterol concentrations, and uterine endometrium in postmenopausal women. New England Journal of Medicine, 337, 1641-1647.
21. Finking G., Hess B., Lenz C., Wohlfrom M. and Hanke H. (1999) The effect of 17β-estradiol, and the phytoestrogens gemstein and daidzein on neointima development in endothelium-denuded female rabbit aortae - an in vitro study. Endothelium (in press).
22. Gilligan D. M., Quyyumi A. A. and Cannon III R. O. (1994) Effects of physiological levels of estrogen on coronary vasomotor function in postmenopausal women. Circulation, 89, 2545-2551 (abstract).
23. Grodstein F., Stampfer M. J., Colditz G. A., Willett W. C., Manson J. E., Joffe M., Rosner B., Fuchs C., Hankinson S. E., Hunter D. J., Hennekens C. H. and Speizer F. E. (1997) Postmenopausal hormone therapy and mortality. New England Journal of Medicine, 336, 1769-1775.
24. Hanke H., Hanke S., Bruck B., Brehme U., Gugel N., Finking G., Muck A. O., Schmahl F. W., Hombach V. and Haasis R. (1996a) Inhibition of the protective effect of estrogen by progesterone in experimental atherosclerosis. Atherosclerosis, 121, 129-138.
25. Hanke S., Finking G., Brehme U., Bruck B., Gugel N., Däuble C., Haasis R., Hombach V. and Hanke H. (1996b) Wirkung von Progesteron auf den atheroprotektiven Effekt von Ostrogen an cinem experimentellen Atherosklerose-modell. Perfusion, 9, 433-438.
26. Hanke H., Hanke S., Ickrath O., Lange K., Bruck B., Mück A. O., Seeger H., Zwirner M., Voisard R., Haasis R. and Hombach V. (1997) Estradiol concentrations in premeno-pausal women with coronary heart disease. Coronary Artery Disease. 8, 511-515.
27. Hayashi T., Fukuto J. M., Ignarro L. J. and Chaudhuri G. (1992) Basal release of nitric oxide from aortic rings is greater in female rabbits than in male rabbits: implications for atherosclerosis. Proceedings of the National Academy of Sciences of the USA, 89, 11259-11263.
28. Honore E. K., Williams J. K., Anthony M. S. and Clarkson T. B. (1997) Soy isoflavones enhance coronary vascular reactivity in atherosclerotic female macaques. Fertility and Sterility, 67, 148-154.
29. Hughes C. L. J. (1987-1988) Effects of phytoestrogens on GnRH-induced luteinizing hormone secretion in ovaricetomized rats. Reproductive Toxiology, 1, 179-181.
30. Hulka B. S., Kaufman D. G., Fowler W. C., Grimson R. C. and Greenberg B. G. (1980) Predominance of early endometrial cancers after long-term estrogen use. Journal of the American Medical Association, 244, 2419-2422.
31. Hulley S., Grady D., Bush T., Furberg C., Herrington D., Riggs B. and Vittinghoff E. (1998) Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Journal of the American Medical Association, 280, 605-613.
32. Jiang C., Sarrel P. M., Lindsay D. C., Poole-Wilson P. A. and Collins P. (1991) Endothelium-independent relaxation of rabbit coronary artery by 17β-oestradiol in vitro. British Journal of Pharmacology, 104, 1033-1037.
33. Jiang C., Poole-Wilson P. A., Sarrel P. M., Mochizuki S., Collins P. and MacLeod K. T. (1992) Effect of 17β-oestradiol on contraction, Ca-2+ current and intracellular free Ca-2+ in guinea-pig isolated cardiac myocytes. British Journal of Pharmacology, 106, 739-745.
34. Jonas J. C., Plant T. D., Gilon P., Detimary P., Nenquin M. and Henquin J. C. (1995) Multiple effects and stimulation of insulin secretion by the tyrosine kinase inhibitor genistein in normal mouse islets. British Journal of Pharmacology, 114, 872-880.
35. Kanazawa T., Osanai T., Zhang X. S., Uemura T., Yin X. Z., Onodera K., Oike Y. and Ohkubo K. (1995) Protective effects of soy protein on the peroxidizability of lipoproteins in cerebrovascular diseases. Journal of Nutrition, 125, 639S-646S.
36. Kannel B. W., Hjortland M. C., McNamara P. M. and Gordon T. (1976) Menopause and risk of cardiovascular diseases. The Framingham Study. Annals of Internal Medicine, 85, 447-452.
37. Krol W., Czuba Z. P., Threadgill M. D., Cunningham B. D. and Pietsz G. (1995) Inhibition of nitric oxide (NO) production in murine macrophages by flavones. Biochemical Pharmacology. 50, 1031-1035.
38. Lindner H. R. (1976) Occurrence of anabolic agents in plants and their importance. Environment Quality anti Safety Supplement, 5, 151-158.
39. Lindsay R. (1989) Pathogenesis of postmenopausal osteoporosis. Clinical Endocrinology and Metabolis, 3, 500-513.
40. Loch E.-G. (1998) Hormonbehandlung des alternden Menschen; 22. Interdisziplinäres Forum der Bundesärz-tekammer 'Fortschritt und Fortbildung in der Medizin' vom 28. bis 31. Januar 1998. Deutsches Arzteblatt, 95, C-859-C-861.
41. Ludden J. B., Bruger M. and Wright I. S. (1942) Effect of testosterone propionate and estradiol dipropionate on experimental atherosclerosis in rabbits. Archives of Pathology, 33, 58-62.
42. Paul A., Pendreigh R. H. and Plevin R. (1995) Protein kinase C and tyrosine kinase pathways regulate lipo-polysaccharide-induced nitric oxide synthase activity in RAW 264.7 murine macrophages. British Journal of Pharmacology, 114, 482-488.
43. Pelissero C., Flouriot G., Foucher J. L., Bennetau B., Dunoguès J., Le-Gac F. and Sumpter J. P. (1993) Vitello-genin synthesis in cultured hepatocytes; an in vitro test for the estrogenic potency of chemicals. Journal of Steroidal and Biochemical and Molecular Biology, 44, 263-272.
44. Potter S. (1995) Overview of proposed mechanisms for the hypocholesterolemic effect of soy. Journal of Nutrition, 125, supplement 3, 606S-611S.
45. Radomski M. W., Palmer R. M. and Moncada S. (1987) Endogenous nitric oxide inhibits human platelet adhesion to vascular endothelium. Lancet, 2, 1057-1058 (abstract).
46. Reinli K. and Block G. (1996) Phytoestrogen content of foods a compendium of literature values. Nutrition and Cancer, 26, 123-148.
47. Riedel M., Rafflenbeul W. and Lichtlen P. (1993) Ovarian sex steroids and atherosclerosis. Clinical Investigations, 71, 406-412.
48. Rosenblum E. R., Stauber R. E., Van-Thiel D. H., Campbell I. M. and Gavaler J. S. (1993) Assessment of the estrogenic activity of phytoestrogens isolated from bourbon and beer. Alcohol Clinical and Experimental Research, 17, 1207-1209.
49. Sack M. N., Rader D. J. and Cannon III R. O. (1994) Oestrogen and inhibition of oxidation of low-density lipo-proteins in postmenopausal women. Lancet, 343, 269-270.
50. Sirtori C. R., Lovati M. R., Manzoni C., Monetti M., Pazzucconi F. and Gatti E. (1995) Soy and cholesterol reduction: clinical experience. Journal of Nutrition, 125, 598S-605S.
51. Stampfer M. J., Colditz G. A., Willett W. C., Manson J. E., Rosner B., Speizer F. E. and Hennekens C. H. (1991) Post-menopausal estrogen therapy and cardiovascular disease. Ten-year follow-up from the nurses' health study. New England Journal of Medicine, 11, 756-762.
52. Sullivan J. M., Vander Zwag R., Hughes J. P., Maddock V., Kroetz F. W., Ramanathan K. B. and Mirvis D. M. (1990) Estrogen replacement and coronary artery disease. Effect on survival in postmenopausal women. Archives of Internal Medicine, 150, 2557-2562.
53. Wagner J. D., Washburn S. A., Zhang L., Honoré E. K., Williams J. K. and Schwenke C. (1995) A non-feminizing conjugated equine estrogen decreases arterial LDL degradation and improves vascular reactivity in male rhesus monkeys. Circulation, 92, I 627 (abstract).
54. Wagner J. D., Cefalu W. T., Anthony M. S., Litwak K. N., Zhang L. and Clarkson T. B. (1997) Dietary soy protein and estrogen replacement therapy improve cardiovascular risk factors and decrease aortic cholesteryl ester content in ovariectomized cynomolgus monkeys. Metabolism, 46, 698-705.
55. Walsh B. W., Schiff I., Rosner B., Greenberg L., Ravnikar V. and Sacks F. M. (1991) Effects of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoproteins. New England Journal of Medicine, 325, 1196-1204.
56. Warren M. P., Brooks-Gunn J., Hamilton L. H.. Warren L. F. and Hamilton W. G. (1986) Skoliosis and fractures in young ballet dancers. Relation to delayed menarche and secondary amenorrhooea. New England Journal of Medicine, 314, 1348-1358.
57. Washburn S. A., Adams M. R., Clarkson T. B. and Adelman S. J. (1993) A conjugated equine estrogen with differential effects on uterine weight and plasma cholesterol in the rat. American Journal of Obstetrics and Gynecology, 169, 251-256.
58. Washburn S. A., Honoré E. K., Cline J. M., Helman M., Wagner J. D., Adelman S. J. and Clarkson T. B. (1996) Effects of 17α-dihydroequilenin sulfate on atherosclerotic male and female rhesus monkeys. American Journal of Obstetrics and Gynecology, 175, 341-351.
59. Wijetunge S., Aalkjaer C., Schachter M. and Hughes A. D. (1992) Tyrosine kinase inhibitors block calcium channel currents in vascular smooth muscle cells. Biochemical and Biophysical Research Communications. 189, 1620-1623.
60. Williams J. K. and Adams M. R. (1997) Estrogens, progestins and coronary reactivity. Nature Medicine, 3, 273-274.
61. Williams J. K., Adams M. R. and Klopfstein H. S. (1990) Estrogen modulates responses of atherosclerotic coronary arteries. Circulation, 81, 1680-1687.